Skip to main content
Erschienen in: Surgical Endoscopy 5/2010

01.05.2010

Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes

verfasst von: F. Abbatini, M. Rizzello, G. Casella, G. Alessandri, D. Capoccia, F. Leonetti, N. Basso

Erschienen in: Surgical Endoscopy | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

This study aimed to compare the efficacy of laparoscopic sleeve gastrectomy (SG) with that of laparoscopic gastric bypass (GBP) and laparoscopic adjustable gastric banding (AGB) for glucose homeostasis in morbidly obese subjects with type 2 diabetes mellitus (T2DM) at a 3-year follow-up assessment and to elucidate the role of weight loss in the T2DM resolution after SG.

Methods

For this study, 60 morbidly obese T2DM patients (44 females and 16 males) who underwent AGB (24 patients), GBP (16 patients), or SG (20 patients) between 1996 and 2008 were retrospectively analyzed. Age, sex, body mass index (BMI), estimated weight loss (EWL), fasting glycemia, HbA1c, euglycemic hyperinsulinemic clamp, discontinuation of diabetes treatment, and time until interruption of therapy were evaluated.

Results

In the study, 54 patients received oral hypoglycemic agents for at least 12 months before surgery, and 6 patients received insulin. The mean follow-up period was 36 months. The resolution rate was 60.8% for the AGB patients, 81.2% for the GBP patients, and 80.9% for the SG patients. The postoperative time until interruption of therapy was 12.6 months for the AGB patients, 3.2 months for the GBP patients, and 3.3 months for the SG patients. The hyperinsulinemic euglycemic clamp test was performed 12 months after surgery for the cured patients. Insulin resistance was restored to normal values in all the patients. The greatest improvement from preoperative values occurred in the SG group. For the not-cured GBP and SG patients, an improvement of 120 mg/dl in fasting plasma glucose was observed 3 months after the surgery, suggesting an enhancement in insulin sensitivity, which determines better medical control. The resolution rate remained constant at the 36-month follow-up evaluation in both the GBP and SG groups.

Conclusions

All three bariatric procedures are effective in treating diabetes, with a 3-year follow-up evaluation showing an effect that lasts. The AGB procedure was the least effective. The antidiabetic effect was similarly precocious after GBP and SG compared with AGB. This difference may indicate that a hormonal mechanism may be involved, independent of weight loss.
Literatur
1.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737CrossRefPubMed
2.
Zurück zum Zitat Elder KA, Wolfe BM (2007) Bariatric surgery: a review of procedures and outcomes. Gastroenterology 132:2253–2271CrossRefPubMed Elder KA, Wolfe BM (2007) Bariatric surgery: a review of procedures and outcomes. Gastroenterology 132:2253–2271CrossRefPubMed
3.
Zurück zum Zitat Deitel M, Crosby RD, Gagner M (2008) The first international consensus summit for Sleeve Gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg 18:487–496CrossRefPubMed Deitel M, Crosby RD, Gagner M (2008) The first international consensus summit for Sleeve Gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg 18:487–496CrossRefPubMed
4.
Zurück zum Zitat Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13:861–864CrossRefPubMed Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13:861–864CrossRefPubMed
5.
Zurück zum Zitat Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double-blind study. Ann Surg 247:401–407CrossRefPubMed Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double-blind study. Ann Surg 247:401–407CrossRefPubMed
6.
Zurück zum Zitat Lee CM, Cirangle PT, Jossart GH (2007) Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc 21:1810–1816 Epub. 14 March 2007CrossRefPubMed Lee CM, Cirangle PT, Jossart GH (2007) Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc 21:1810–1816 Epub. 14 March 2007CrossRefPubMed
7.
Zurück zum Zitat Himpens J, Dapri G, Cadière GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456CrossRefPubMed Himpens J, Dapri G, Cadière GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456CrossRefPubMed
8.
Zurück zum Zitat Cummings DE, Overduin J, Foster-Schubert KE (2004) Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 89:2608–2615CrossRefPubMed Cummings DE, Overduin J, Foster-Schubert KE (2004) Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 89:2608–2615CrossRefPubMed
9.
Zurück zum Zitat Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484; discussion 84–85PubMed Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484; discussion 84–85PubMed
10.
Zurück zum Zitat Sugerman HJ, Wolfe LG, Sica DA, Clore JN (2003) Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237:751–756CrossRefPubMed Sugerman HJ, Wolfe LG, Sica DA, Clore JN (2003) Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237:751–756CrossRefPubMed
11.
Zurück zum Zitat Sjöström CD, Lissner L, Wedel H, Sjöström L (1999) Reduction in incidence of diabetes, hypertension, and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 7:477–484PubMed Sjöström CD, Lissner L, Wedel H, Sjöström L (1999) Reduction in incidence of diabetes, hypertension, and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 7:477–484PubMed
12.
Zurück zum Zitat Pories WJ, Mac Donald KG, Jr Morgan EJ, Sinha MK, Dohm GL, Swanson MS et al (1992) Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr 55(2 Suppl):582S–585SPubMed Pories WJ, Mac Donald KG, Jr Morgan EJ, Sinha MK, Dohm GL, Swanson MS et al (1992) Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr 55(2 Suppl):582S–585SPubMed
13.
Zurück zum Zitat Hickey MS, Pories WJ, MacDonald KG Jr, Cory KA, Dohm GL, Swanson MS, Israel RG, Barakat HA, Considine RV, Caro JF, Houmard JA (1998) A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 227:637–643CrossRefPubMed Hickey MS, Pories WJ, MacDonald KG Jr, Cory KA, Dohm GL, Swanson MS, Israel RG, Barakat HA, Considine RV, Caro JF, Houmard JA (1998) A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 227:637–643CrossRefPubMed
14.
Zurück zum Zitat Mingrone G (2008) Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis 18:574–579CrossRefPubMed Mingrone G (2008) Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis 18:574–579CrossRefPubMed
15.
Zurück zum Zitat Vidal J, Ibarzabal A, Romero F, Delgado S, Momblán D, Flores L, Lacy A (2008) Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 18:1077–1082CrossRefPubMed Vidal J, Ibarzabal A, Romero F, Delgado S, Momblán D, Flores L, Lacy A (2008) Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 18:1077–1082CrossRefPubMed
16.
Zurück zum Zitat DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed
17.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
18.
Zurück zum Zitat Belachew M, Jacqet P, Lardinois F, Karler C (1993) Vertical banded gastroplasty vs adjustable silicone gastric banding in the treatment of morbid obesity: a preliminary report. Obes Surg 3:275–278CrossRefPubMed Belachew M, Jacqet P, Lardinois F, Karler C (1993) Vertical banded gastroplasty vs adjustable silicone gastric banding in the treatment of morbid obesity: a preliminary report. Obes Surg 3:275–278CrossRefPubMed
19.
Zurück zum Zitat Inabnet WB, Quinn T, Gagner M, Urban M, Pomp A (2005) Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths. Obes Surg 15(1):51–57 Inabnet WB, Quinn T, Gagner M, Urban M, Pomp A (2005) Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths. Obes Surg 15(1):51–57
20.
Zurück zum Zitat Shulman GI (1999) Cellular mechanisms of insulin resistance in humans. Am J Cardiol 84:3J–10JCrossRefPubMed Shulman GI (1999) Cellular mechanisms of insulin resistance in humans. Am J Cardiol 84:3J–10JCrossRefPubMed
21.
22.
Zurück zum Zitat Friedman JM (2000) Obesity in the new millennium. Nature 404:632–634PubMed Friedman JM (2000) Obesity in the new millennium. Nature 404:632–634PubMed
23.
Zurück zum Zitat Fischer S, Hanefeld M, Haffner SM, Fusch C, Schwanebeck U, Köhler C, Fücker K, Julius U (2002) Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol 39:105–110CrossRefPubMed Fischer S, Hanefeld M, Haffner SM, Fusch C, Schwanebeck U, Köhler C, Fücker K, Julius U (2002) Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol 39:105–110CrossRefPubMed
24.
Zurück zum Zitat Franssila-Kallunki A, Rissanen A, Ekstrand A, Ollus A, Groop L (1992) Weight loss by very-low-calorie diets: effects on substrate oxidation, energy expenditure, and insulin sensitivity in obese subjects. Am J Clin Nutr 56(1 Suppl):247S–248SPubMed Franssila-Kallunki A, Rissanen A, Ekstrand A, Ollus A, Groop L (1992) Weight loss by very-low-calorie diets: effects on substrate oxidation, energy expenditure, and insulin sensitivity in obese subjects. Am J Clin Nutr 56(1 Suppl):247S–248SPubMed
25.
Zurück zum Zitat Cummings S, Apovian CM, Khaodhiar L (2008) Obesity surgery: evidence for diabetes prevention/management. J Am Diet Assoc 108(4 Suppl 1):S40–S44CrossRefPubMed Cummings S, Apovian CM, Khaodhiar L (2008) Obesity surgery: evidence for diabetes prevention/management. J Am Diet Assoc 108(4 Suppl 1):S40–S44CrossRefPubMed
26.
Zurück zum Zitat Yada T, Dezaki K, Sone H, Koizumi M, Damdindorj B, Nakata M, Kakei M (2008) Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev 4:18–23CrossRefPubMed Yada T, Dezaki K, Sone H, Koizumi M, Damdindorj B, Nakata M, Kakei M (2008) Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev 4:18–23CrossRefPubMed
27.
Zurück zum Zitat Micic D, Duntas L, Cvijovic G, Kendereski A, Sumarac-Dumanovic M, Jehle P, Zoric S, Pejkovic D, Lague M, Dieguez C, Casanueva F (2007) Ghrelin and the enteroinsular axis in healthy men. Hormones (Athens) 6:321–326 Micic D, Duntas L, Cvijovic G, Kendereski A, Sumarac-Dumanovic M, Jehle P, Zoric S, Pejkovic D, Lague M, Dieguez C, Casanueva F (2007) Ghrelin and the enteroinsular axis in healthy men. Hormones (Athens) 6:321–326
28.
Zurück zum Zitat Campbell CD, Lyon HN, Nemesh J, Drake JA, Tuomi T, Gaudet D, Zhu X, Cooper RS, Ardlie KG, Groop LC, Hirschhorn JN (2007) Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men. Diabetes 56:1460–1467CrossRefPubMed Campbell CD, Lyon HN, Nemesh J, Drake JA, Tuomi T, Gaudet D, Zhu X, Cooper RS, Ardlie KG, Groop LC, Hirschhorn JN (2007) Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men. Diabetes 56:1460–1467CrossRefPubMed
Metadaten
Titel
Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes
verfasst von
F. Abbatini
M. Rizzello
G. Casella
G. Alessandri
D. Capoccia
F. Leonetti
N. Basso
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 5/2010
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-009-0715-9

Weitere Artikel der Ausgabe 5/2010

Surgical Endoscopy 5/2010 Zur Ausgabe

News and notices

News and Notices

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.